These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29739297)

  • 21. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
    Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis.
    Meng Y; Zhang C; Zhou X
    Onco Targets Ther; 2016; 9():367-76. PubMed ID: 26855585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
    PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysis.
    Wen L; Hu YY; Yang GL; Liu DX
    Biomed Rep; 2014 Jul; 2(4):549-554. PubMed ID: 24944806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of
    Walia HK; Singh N; Sharma S
    Pharmacogenomics; 2022 Jan; 23(2):97-118. PubMed ID: 34911343
    [No Abstract]   [Full Text] [Related]  

  • 27. Association between cyclin D1 (CCND1) polymorphism and gastric cancer risk in Japanese population.
    Tahara T; Arisawa T; Shibata T; Yamashita H; Hirata I
    Hepatogastroenterology; 2009; 56(93):1232-5. PubMed ID: 19760977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
    Hu YY; Zheng R; Guo C; Niu YM
    Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms in the
    Walia HK; Singh N; Sharma S
    Future Oncol; 2021 Dec; 17(35):4925-4946. PubMed ID: 34672683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population.
    Satinder K; Chander SR; Pushpinder K; Indu G; Veena J
    Mol Cell Biochem; 2008 Aug; 315(1-2):151-7. PubMed ID: 18548202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.
    Cui J; Shen L; Wang Y
    Asian Pac J Cancer Prev; 2012; 13(10):5023-5. PubMed ID: 23244103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B; Cao L; Yang P; Zhou Y; Wu XT
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
    Wang S; Huang Y; Su R; Fang Z; Han M
    Genet Mol Res; 2015 Jun; 14(2):5856-61. PubMed ID: 26125784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M; Zhao F; Zou X; Jin S; Xiong S
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity.
    El Menshawy N; El Marghany AB; Sarhan MM; Aladle DA
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2941-2947. PubMed ID: 33112552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
    Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
    Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
    Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
    Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of
    Singh S; Singh N; Baranwal M; Sharma S
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.